To assess the diagnostic value of RAF1, miR-146b-3p, and Circ-RPL15 expression as biomarkers in AML patients, ROC curves were plotted (Fig. 1) for different sample types (bone marrow and peripheral blood) as well as for the total sample set. This evidence concerns the gene RPL15 and acute myeloid leukemia.